Morgan Stanley Insight Fund Class R6 MCRTX

Medalist Rating as of | See Morgan Stanley Investment Hub
  • NAV / 1-Day Return —  /  —
  • Total Assets —
  • Adj. Expense Ratio
    —
  • Expense Ratio —
  • Distribution Fee Level —
  • Share Class Type —
  • Category —
  • Investment Style —
  • Min. Initial Investment —
  • Status
  • TTM Yield —
  • Turnover —

Morningstar’s Analysis MCRTX

Will MCRTX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Morgan Stanley Insight R6 holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MCRTX

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 64.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Cloudflare Inc

13.20 163M
Technology

Royalty Pharma PLC Class A

7.80 96M
Healthcare

Tesla Inc

7.62 94M
Consumer Cyclical

Affirm Holdings Inc Ordinary Shares - Class A

6.45 80M
Financial Services

IonQ Inc

5.68 70M
Technology

AppLovin Corp Ordinary Shares - Class A

5.06 62M
Communication Services

Space Exploration Technologies Corp Class A

4.86 60M
Industrials

Opendoor Technologies Inc Ordinary Shares - Class A

4.75 59M
Real Estate

Aurora Innovation Inc Class A

4.72 58M
Consumer Cyclical

Roivant Sciences Ltd Ordinary Shares

4.58 56M
Healthcare

Sponsor Center